A nurse is preparing a presentation on Parkinson’s disease (PD) for a health fair at a local community center. Which information should the nurse include in the presentation?

Choice A reason: Finding comfort in family connections is typical of grief, not clinical depression. Grief involves sadness but often retains social engagement, whereas depression involves persistent isolation and anhedonia due to serotonin and dopamine dysregulation, making this choice incorrect.

Choice B reason: Loss of appetite occurs in both grief and clinical depression, as stress or serotonin imbalances affect appetite regulation. However, it is not specific to depression, as transient appetite loss is common in grief, making it less definitive than anhedonia.

Choice C reason: Loss of interest in pleasurable activities, or anhedonia, is a hallmark of clinical depression, reflecting disrupted dopamine reward pathways in the brain. Unlike grief’s temporary sadness, this persistent symptom impairs daily functioning, making it a key indicator of clinical depression.

Choice D reason: Intense moments of sadness are characteristic of grief, a normal response to loss, and do not necessarily indicate clinical depression. Depression involves persistent, pervasive symptoms, not episodic sadness, which is driven by situational triggers rather than chronic neurochemical imbalances.

Choice A reason: Alendronate must be taken on an empty stomach with a full glass of water to ensure proper absorption and minimize esophageal irritation. Taking it with a meal reduces its bioavailability, as food interferes with absorption in the gastrointestinal tract. This statement indicates a misunderstanding, requiring further instruction.

Choice B reason: Sitting or standing upright for at least 30 minutes after taking Alendronate is correct, as it prevents esophageal reflux and irritation, a common side effect. This position allows the drug to pass into the stomach, reducing the risk of esophagitis, making this statement accurate and not requiring correction.

Choice C reason: Alendronate works by inhibiting osteoclast activity, preventing bone resorption, and promoting bone density increase. This statement is correct, as the drug’s mechanism supports bone health in osteoporosis patients. It reflects an accurate understanding of the drug’s purpose, so no further instruction is needed here.

Choice D reason: Continuing calcium supplements with Alendronate is correct, as osteoporosis treatment requires adequate calcium and vitamin D to support bone formation. Alendronate enhances bone density, but calcium is essential for its efficacy, making this statement accurate and not requiring additional teaching.